New finding explains severe COVID-19 attacks on the lungs
In some cases, immune cells in the lungs can contribute to worsening a virus attack.
In a new study, researchers found how immune cells called...
New COVID-19 variant growing rapidly in UK, study shows
In a new study, researchers found in the UK, the new SARS-CoV-2 variant is growing rapidly, is more transmissible than other variants, and affecting...
Scientists find safest way driver, passengers can avoid COVID-19
In a new study, researchers found key steps that help cut the odds of COVID-19 spread during traveling with a car.
They found that driving...
Can cannabis help you ease the mind in the age of COVID-19?
In a new study, researchers measured the effectiveness of commercially available Cannabis flower, or "buds," for alleviating feelings of stress and anxiety.
They used data...
Your wearable fitness tracker may help distinguish COVID-19 from flu
In a new study, researchers analyzed heart rate, step count, and symptom duration in patients with flu and those with COVID-19 using Fitbit data...
Blood pressure drugs unlikely to increase COVID-19 risk, Stanford study shows
In a new study, researchers found that cells in the nasal passages and upper airways are likely the coronavirus's major point of entry into...
5 things you need to do while waiting for the COVID-19 vaccine
Even as vaccinations against COVID-19 begin, the virus continues to kill thousands of Americans every day, making it more important than ever to stay...
Immune cell activation in severe COVID-19 similar to lupus
In a new study, researchers found that in severe cases of COVID-19, there is an exuberant activation of immune cells, resembling lupus, an autoimmune...
These common health issues may increase brain damage in COVID-19
The virus that causes COVID-19 first attacks cells in the respiratory system, often leading to an inflammation of the lungs that puts people at...
This drug may improve survival in people with diabetes and COVID-19
Sitagliptin, an oral drug, is prescribed to 15% to 20% of patients with type 2 diabetes.
It was approved by the FDA in 2006 and...